These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1183137)

  • 21. [Improvement of package insert CYP information for prescription drugs marketed in Japan].
    Hirata-Koizumi M; Saito M; Urano T; Miyake S; Hasegawa R
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2005; (123):12-8. PubMed ID: 16541745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The patient package insert. Is it safe and effective?
    Dorsey R
    JAMA; 1977 Oct; 238(18):1936-9. PubMed ID: 578554
    [No Abstract]   [Full Text] [Related]  

  • 23. Use of Pharmacist Consultations for Nonprescription Laxatives in Japan: An Online Survey.
    Shibata K; Matsumoto A; Nakagawa A; Akagawa K; Nakamura A; Yamamoto T; Kurata N
    Biol Pharm Bull; 2016; 39(11):1767-1773. PubMed ID: 27803447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Administering medications in the occupational health setting.
    Bartko M
    Occup Health Saf; 1980 Sep; 49(8):58-60, 62. PubMed ID: 7413130
    [No Abstract]   [Full Text] [Related]  

  • 25. [Establishing a System for Effectively Explaining Indications for Driving Prohibition Contained in Drug Package Inserts].
    Tanaka M
    Yakugaku Zasshi; 2017; 137(3):337-340. PubMed ID: 28250330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ASHP statement on hospital drug control systems.
    Am J Hosp Pharm; 1974 Dec; 31(12):1198-207. PubMed ID: 4458439
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of renal drug dosing: prescribing information and clinical pharmacist approaches.
    Dowling TC; Matzke GR; Murphy JE; Burckart GJ
    Pharmacotherapy; 2010 Aug; 30(8):776-86. PubMed ID: 20653353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacist--dedicated to the prevention of drug toxicity.
    Oderda GM
    Drug Intell Clin Pharm; 1977 Mar; 11(3):176-7. PubMed ID: 10235795
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?
    Worley MM; Schommer JC; Brown LM; Hadsall RS; Ranelli PL; Stratton TP; Uden DL
    Res Social Adm Pharm; 2007 Mar; 3(1):47-69. PubMed ID: 17350557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of prescribing information for generic drugs manufactured in the Middle East and marketed in Saudi Arabia.
    Gebran N; Al Haidari K
    Ann Saudi Med; 2006; 26(3):192-9. PubMed ID: 16861873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Editorial: Patient package inserts.
    Zellment WA
    Am J Hosp Pharm; 1976 Jun; 33(6):535. PubMed ID: 1274970
    [No Abstract]   [Full Text] [Related]  

  • 32. Pharmaceutical inserts: legal consequences.
    Hirsh HL
    Hosp Med Staff; 1979 Jul; 8(7):2-6. PubMed ID: 10242674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of written drug information on patient knowledge and compliance: a literature review.
    Morris LA; Halperin JA
    Am J Public Health; 1979 Jan; 69(1):47-52. PubMed ID: 105645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Individual medication management system (IMMS) implementation in pharmacists' opinion.
    Waszyk-Nowaczyk M; Lawicki S; Michalak M; Simon M
    Acta Pol Pharm; 2014; 71(3):509-14. PubMed ID: 25265831
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consumer understanding of prescription drug information: an illustration using an antidepressant medication.
    Shiffman S; Gerlach KK; Sembower MA; Rohay JM
    Ann Pharmacother; 2011 Apr; 45(4):452-8. PubMed ID: 21427296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [INFORMATION ON DRUGS].
    Foucher JP
    J Int Bioethique Ethique Sci; 2015 Mar; 26(1):65-72, 101-2. PubMed ID: 26606769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient package inserts: what effects can we expect?
    Morris LA; Gagliardi VJ
    Drug Inf J; 1977; 11(1):17-22. PubMed ID: 10304965
    [No Abstract]   [Full Text] [Related]  

  • 38. Optimizing information on drug exposure by collection of package code information in questionnaire surveys.
    Quinzler R; Schmitt SP; Szecsenyi J; Haefeli WE
    Pharmacoepidemiol Drug Saf; 2007 Sep; 16(9):1024-30. PubMed ID: 17457950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excessive medical information increase in package inserts.
    Fuchs J; Werner S; Scheunpflug C; Götze EA; Elstermann K; Scheffel K; Domnowski A; Peter G; Hertzsch C; Hippius M
    Int J Clin Pharmacol Ther; 2010 Dec; 48(12):781-90. PubMed ID: 21084033
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Questionnaire Survey to Pharmacists after a Workshop on the Chemical Structural Formula of Drugs].
    Shimizu T; Nishimura K; Ueda M
    Yakugaku Zasshi; 2018; 138(8):1085-1093. PubMed ID: 30068849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.